TITLE

Sesquiterpenes: Natural Products That Decrease Cancer Growth

AUTHOR(S)
Modzelewska, Aneta; Sur, Surojit; Kumar, Srinivas K.; Khan, Saeed R.
PUB. DATE
September 2005
SOURCE
Current Medicinal Chemistry - Anti-Cancer Agents;Sep2005, Vol. 5 Issue 5, p477
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Despite recent advances in our understanding of the biological processes leading to the development of cancer, there is still a need for new and effective agents to help bring this disease under control. One of the oldest and most effective strategies for developing new chemotherapeutics is the isolation and evaluation of chemicals of natural origin. The importance of natural products for drug discovery has been impressive: One has to only look at the number of clinically active drugs that are used in cancer therapy to see how many are either natural products or are based on natural products. It is also apparent that materials from natural sources are excellent probes (indicators) for cellular targets that, when modulated, may have a deleterious effect upon the survival or proliferation of tumor cells. And the search goes on. Sesquiterpenes are a class of naturally occurring molecules that have demonstrated therapeutic potential in decreasing the progression of cancer. These molecules are 15-carbon isoprenoid compounds that are typically found in plants and marine life. Although this class of compounds has frequently provided encouraging leads for chemotherapeutics, they have not been evaluated as potential anticancer agents. In this review, we provide a current overview of sesquiterpenoids that have potential as anticancer agents.
ACCESSION #
18105216

Tags: SESQUITERPENES;  CANCER -- Treatment;  TUMORS -- Growth;  CANCER cells;  ANTINEOPLASTIC agents;  ISOPENTENOIDS

 

Related Articles

  • Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer. Yanfeng Qi; Xueqi Fu; Zhenggang Xiong; Haitao Zhang; Steven M. Hill; Brian G. Rowan; Yan Dong // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    A major challenge in breast cancer therapy is the lack of an effective therapeutic option for a particularly aggressive subtype of breast cancer, triple-negative breast cancer. Here we provide the first preclinical evidence that a second-generation selenium compound, methylseleninic acid,...

  • Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer. Yanfeng Qi; Xueqi Fu; Zhenggang Xiong; Haitao Zhang; Steven M. Hill; Brian G. Rowan; Yan Dong // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    A major challenge in breast cancer therapy is the lack of an effective therapeutic option for a particularly aggressive subtype of breast cancer, triple-negative breast cancer. Here we provide the first preclinical evidence that a second-generation selenium compound, methylseleninic acid,...

  • Amazing IL-9: revealing a new function for an "old" cytokine. Schmitt, Edgar; Bopp, Tobias // Journal of Clinical Investigation;Nov2012, Vol. 122 Issue 11, p3857 

    The incidence of melanoma -- the most aggressive form of skin cancer -- is dramatically increasing, while the development of innovative therapeutic strategies continues to be challenging, especially due to a lack of knowledge about the molecular mechanisms underlying melanoma progression as well...

  • Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development. Lavilla-Alonso, S; Bauer, M M T; Abo-Ramadan, U; Ristim�ki, A; Halavaara, J; Desmond, R A; Wang, D; Escutenaire, S; Ahtiainen, L; Saksela, K; Tatlisumak, T; Hemminki, A; Pesonen, S // Cancer Gene Therapy;Feb2012, Vol. 19 Issue 2, p126 

    Oncolytic adenoviruses are a promising treatment alternative for many advanced cancers, including colorectal cancer. However, clinical trials have demonstrated that single-agent therapy in advanced tumor masses is rarely curative. Poor spreading of the virus through tumor tissue is one of the...

  • Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradation. Zhang, B; Qian, D; Ma, H-H; Jin, R; Yang, P-X; Cai, M-Y; Liu, Y-H; Liao, Y-J; Deng, H-X; Mai, S-J; Zhang, H; Zeng, Y-X; Lin, M C; Kung, H-F; Xie, D; Huang, J-J // Oncogene;1/5/2012, Vol. 31 Issue 1, p1 

    Telomere maintenance is essential for cancer growth. Induction of telomere dysfunction, for example, by inhibition of telomeric proteins or telomerase, has been shown to strongly enhance cancer cells' sensitivity to chemotherapies. However, it is not clear whether modulations of telomere...

  • Metronomic Therapy: Chemotherapy revisited. Noronha, V.; Krishna, M. V.; Patil, V.; Joshi, A.; Banavali, S. D.; Prabhash, K. // Indian Journal of Cancer; 

    Cytotoxic antiproliferative chemotherapeutic agents are the mainstay of treatment in cancers. Chemotherapy is usually administered every 2-3 weeks. Along with acute toxicity and long-term effects of cumulative doses, this strategy potentially allows regrowth of the tumor in the interval period...

  • Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine. Chen, Hui-Ming; Wang, Pi-Hsueh; Chen, Swey-Shen; Wen, Chih-Chun; Chen, Yun-Hsiang; Yang, Wen-Chin; Yang, Ning-Sun // Cancer Immunology, Immunotherapy;Nov2012, Vol. 61 Issue 11, p1989 

    Immunogenic cell death is characterized by damage-associated molecular patterns, which can enhance the maturation and antigen uptake of dendritic cells. Shikonin, an anti-inflammatory and antitumor phytochemical, was exploited here as an adjuvant for dendritic cell-based cancer vaccines via...

  • Cytotoxic Activity of Laserpitium latifolium L. Extract and Its Daucane and Phenylpropanoid Constituents. Popović, Višnja; Heyerick, Arne; Petrović, Silvana; Van Calenbergh, Serge; Karalić, Izet; Niketić, Marjan; Deforce, Dieter // Records of Natural Products;Jul2013, Vol. 7 Issue 3, p245 

    In the search for novel cytotoxic agents, sesquiterpenoids and phenylpropanoids have provided interesting lead compounds. From the chloroform extract of the underground parts of Laserpitium latifolium, the daucane sesquiterpenoids laserpitin and acetyldesoxodehydrolaserpitin, and the...

  • Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. Jeffrey Dyason; Ruth Freeman; Lan-Feng Dong; Lubomir Prochazka; Xiu-Fang Wang; Immo Scheffler; Stephen Ralph // Journal of Bioenergetics & Biomembranes;Feb2007, Vol. 39 Issue 1, p65 

    Abstract  Recently mitochondria in cancer cells have emerged as the Achilles heel for tumour destruction. Anti-cancer agents specifically targeting cancer cell mitochondria are referred to as ‘mitocans’. These compounds act by destabilising these organelles, unleashing their...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics